Page 6 - Pfizer

Stocks to Watch: ITC, Zomato, Eicher Motors, Hero Moto, Voltas, Telcos

Stocks to Watch today: Cigarettes-to-hotels major ITC on Monday reported a 33.98 per cent year-on-year (YoY) jump in its consolidated net profit, which came in at Rs 4,389.76 crore

Biden feeling well, isolating after rebound case of Covid: WH doctor

'Given his rebound positivity which we reported yesterday, we continued daily monitoring. This morning, unsurprisingly, his SARS-CoV-2 antigen testing remained positive,' the physician said

Covid: Paxlovid rebound can be contagious even with no symptoms, says study

US President Joe Biden, who first tested positive for Covid-19 on July 21, before receiving his negative testing results, earlier this week, has tested positive again in a "rebound" case

Nasal sprays will be essential to tackle emerging Covid-19 variants: Study

Researchers noted that the widely available Covid-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants.

Moderna to advance two Omicron vaccine candidates against newer variants

Moderna said its decision to develop the bivalent vaccines was based on different market preferences for shots against the subvariants.

US donates 33,600 doses of Pfizer's pediatric Covid vaccine to Bhutan

The US government on Sunday delivered 33,600 doses of Pfizer's pediatric COVID-19 vaccine to Bhutan. The US embassy in India said the vaccine doses were supplied as part of President Joe Biden's commitment to helping countries around the world to deal with the pandemic. It said these "safe and effective" pediatric vaccine doses will protect the lives of children in Bhutan and help stop the spread of COVID-19. "As part of President Biden's commitment to donate COVID-19 vaccine doses to countries around the world, the US government has delivered 33,600 doses of the Pfizer pediatric COVID-19 vaccine to Bhutan, in partnership with COVAX and the Bhutan Foundation," it said in a statement. USAID's Mission Director to India and Bhutan Veena Reddy said, "The US is committed to a global COVID-19 response because it makes us all stronger and safer -- Americans and Bhutanese alike." "The USAID is proud to work with the Royal Government of Bhutan and our partner, the Bhutan Foundation, to del

USFDA authorises pharmacists to prescribe Pfizer's coronavirus pill

Use of the pill which is now authorized to treat newly infected, at-risk people to prevent severe illness, has however jumped in recent weeks as infections rise

Omicron-targeting Covid vax shows high immune response: Pfizer & BioNTech

A booster dose of the Omicron-adapted bivalent candidates conferred a 9.1 and 10.9-fold increase in neutralising antibodies against Omicron BA.1, that was circulating last winter

Covid vaccines prevented 20 million deaths in first year of rollout: Study

While more than 7 million deaths were likely averted in countries covered by Covax, the WHO-backed distribution program, the research nonetheless highlights the devastation caused by uneven access

FDA opens way to Covid-19 vaccine for children under five: Report

Pfizer's is already authorized for those over the age of 5

Pfizer's Covid vaccine safe and effective for kids under 5: US FDA

The US Food and Drug Administration (FDA) said that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children under 5-years-old

Sanofi, GSK say Covid booster shot works better against Omicron variant

The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.

US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients

On Tuesday, the CDC, citing case reports and concerns that relapsed patients could spread the virus, issued its advisory that Paxlovid users should isolate for a second five days if symptoms rebound

WEF 2022: Pfizer commits medicines, vaccines to 45 lower-income countries

World Economic Forum (WEF) 2022: The initiative by Pfizer was launched at the World Economic Forum Annual Meeting in Davos 2022

Pfizer to offer all its drugs not-for-profit to 45 lower-income countries

Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers

Pfizer to offer nearly two dozen low-cost products to poor nations

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions

Pfizer's three-dose coronavirus vaccine 80% effective in young kids

Pfizer said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old

Pfizer/BioNTech say three Covid shots generate good response in under-5s

Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday.

US FDA authorises Pfizer booster shots for children aged 5-11 yrs

The US FDA has granted emergency use authorisation for a booster dose of the Pfizer-BioNTech vaccine for children aged between 5-11 years at least 5 months after completion of primary vaccine series

Cipla will use Covid-19 bulk drugs inventory when demand rises

The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said